Publications of Louis M. Pelus - IUSM ReSEARCH Connect

114 Publications

This view shows all the publications associated to this researcher. Select a tab to view the documents within each secion. If you are an authorized user, you can add content by selecting the Edit your profile button above. Access to this tool is managed by a project team at your institution.

Jump to:

Books
Book Chapters
Conference Proceedings
Meeting Abstracts
Presentations
Technical Reports
Other Written Works

114 Publications From Scopus

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

sort by year | cited by

Select All | Save icon

Export

1.
2013

Jonathan Hoggatt; Pratibha Singh; Kayla N. Stilger; P. Artur Plett; Carol H. Sampson; Hui Lin Chua; Christie M. Orschell; Louis M. Pelus

Recovery from hematopoietic injury by modulating prostaglandin E₂ signaling post-irradiation
Blood Cells, Molecules, and Diseases. 2013;50(3):147-153.

0
2.
2013

Jonathan Hoggatt; Khalid S. Mohammad; Pratibha Singh; Amber F. Hoggatt; Brahmananda R. Chitteti; Jennifer M. Speth; Peirong Hu; Bradley A. Poteat; Kayla N. Stilger; Francesca Ferraro; et al.

Differential stem-and progenitor-cell trafficking by prostaglandin e 2
Nature. 2013;495(7441):365-369.

1
3.
2012

Pratibha Singh; Jonathan Hoggatt; Peirong Hu; Jennifer M. Speth; Seiji Fukuda; Richard M. Breyer; Louis M. Pelus

Blockade of prostaglandin E ₂ signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells
Blood. 2012;119(7):1671-1682.

5
4.
2012

P. Singh; P. Hu; J. Hoggatt; A. Moh; L.M. Pelus

Expansion of bone marrow neutrophils following G-CSF administration in mice results in osteolineage cell apoptosis and mobilization of hematopoietic stem and progenitor cells
Leukemia. 2012;26(11):2375-2383.

1
5.
2012

Hal E. Broxmeyer; Jonathan Hoggatt; Heather A. O'leary; Charlie Mantel; Brahmananda R. Chitteti; Scott Cooper; Steven Messina-Graham; Giao Hangoc; Sherif Farag; Sara L. Rohrabaugh; et al.

Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis
Nature Medicine. 2012;18(12):1786-1796.

4
6.
2012

Jonathan Hoggatt; Louis M Pelus

Hematopoietic stem cell mobilization with agents other than G-CSF.
Methods in molecular biology (Clifton, N.J.). 2012;904:49-67.

0
7.
2011

Seiji Fukuda; Mariko Abe; Chie Onishi; Takeshi Taketani; Jamiyan Purevsuren; Seiji Yamaguchi; Edward M. Conway; Louis M. Pelus

Survivin selectively modulates genes deregulated in human leukemia stem cells
Journal of Oncology. 2011.

4
8.
2011

Anjaiah Srirangam; Monica Milani; Ranjana Mitra; Zhijun Guo; Mariangellys Rodriguez; Hitesh Kathuria; Seiji Fukuda; Anthony Rizzardi; Stephen Schmechel; David G. Skalnik; et al.

The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin
Journal of Thoracic Oncology. 2011;6(4):661-670.

3
9.
2011

Louis M Pelus; Serif S Farag

Increased mobilization and yield of stem cells using plerixafor in combination with granulocyte-colony stimulating factor for the treatment of non-Hodgkin's lymphoma and multiple myeloma
Stem Cells and Cloning: Advances and Applications. 2011;4(1):11-22.

0
10.
2011

L.M. Pelus; J. Hoggatt; P. Singh

Pulse exposure of haematopoietic grafts to prostaglandin E₂in vitro facilitates engraftment and recovery
Cell Proliferation. 2011;44(SUPPL. 1):22-29.

5
11.
2011

Jonathan Hoggatt; Louis M. Pelus

Many mechanisms mediating mobilization: An alliterative review
Current Opinion in Hematology. 2011;18(4):231-238.

11
12.
2011

Eugene Park; Eun Ji Gang; Yao-Te Hsieh; Paul Schaefer; Sanna Chae; Lars Klemm; Sandra Huantes; Mignon Loh; Edward M. Conway; Eun-Suk Kang; et al.

Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia
Blood. 2011;118(8):2191-2199.

11
13.
2011

Jonathan Hoggatt; Louis M. Pelus

Mobilization of hematopoietic stem cells from the bone marrow niche to the blood compartment
Stem Cell Research and Therapy. 2011;2(2).

3
14.
2011

Louis M. Pelus; Jonathan Hoggatt

Pleiotropic effects of prostaglandin E ₂ in hematopoiesis; Prostaglandin E ₂ and other eicosanoids regulate hematopoietic stem and progenitor cell function
Prostaglandins and Other Lipid Mediators. 2011;96(1-4):3-9.

3
15.
2010

Amber F. Hoggatt; Jonathan Hoggatt; Meghan Honerlaw; Louis M. Pelus

A spoonful of sugar helps the medicine go down: A novel technique to improve oral gavage in mice
Journal of the American Association for Laboratory Animal Science. 2010;49(3):329-334.

8
16.
2010

J. Hoggatt; L.M. Pelus

Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking
Leukemia. 2010;24(12):1993-2002.

20
17.
2009

Jonathan Hoggatt; Pratibha Singh; Janardhan Sampath; Louis M. Pelus

Prostaglandin E₂ enhances hematopoietic stem cell homing, survival, and proliferation
Blood. 2009;113(22):5444-5455.

82
18.
2009

Seiji Fukuda; Pratibha Singh; Akira Moh; Mariko Abe; Edward M. Conway; H. Scott Boswell; Seiji Yamaguchi; Xin-Yuan Fu; Louis M. Pelus

Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3
Blood. 2009;114(2):394-403.

16
19.
2009

Javier Rivera Guzman; Seiji Fukuda; Louis M. Pelus

Inhibition of caspase-3 by Survivin prevents Wee1 Kinase degradation and promotes cell survival by maintaining phosphorylation of p34Cdc2
Gene Therapy and Molecular Biology. 2009;13(2):264-273.

1
20.
2008

L.M. Pelus; S. Fukuda

Chemokine-mobilized adult stem cells; defining a better hematopoietic graft
Leukemia. 2008;22(3):466-473.

34
21.
2008

Louis M Pelus

Peripheral blood stem cell mobilization: New regimens, new cells, where do we stand
Current Opinion in Hematology. 2008;15(4):285-292.

30
22.
2007

Charlie Mantel; Ying Guo; Ryul Lee Man; Min-Kyoung Kim; Myung-Kwan Han; Hirohiko Shibayama; Seiji Fukuda; Mervin C. Yoder; Louis M. Pelus; Kye-Seong Kim; et al.

Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: A source of karyotpic instability
Blood. 2007;109(10):4518-4527.

62
23.
2007

Seiji Fukuda; Huimin Bian; Andrew G. King; Louis M. Pelus

The chemokine GROβ mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment
Blood. 2007;110(3):860-869.

36
24.
2007

Janardhan Sampath; Louis M. Pelus

Alternative splice variants of survivin as potential targets in cancer
Current Drug Discovery Technologies. 2007;4(3):174-191.

29
25.
2007

Seiji Fukuda; Louis M. Pelus

Transmigration of human CD34⁺ cells
Methods in Molecular Biology. 2007;430:55-75.

5
26.
2006

Ying Guo; Giao Hangoc; Huimin Bian; Louis M. Pelus; Hal E. Broxmeyer

Erratum: SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells (Stem Cells (October 2005) 23 (1324-1332) doi: 10.1634/stemcells.2005- 0085)
Stem Cells. 2006;24(1):211.

0
27.
2006

Seiji Fukuda; Louis M. Pelus

Survivin, a cancer target with an emerging role in normal adult tissues
Molecular Cancer Therapeutics. 2006;5(5):1087-1098.

145
28.
2006

Louis M. Pelus; Seiji Fukuda

Peripheral blood stem cell mobilization: The CXCR2 ligand GROβ rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties
Experimental Hematology. 2006;34(8):1010-1020.

51
29.
2006

Hal E. Broxmeyer; Louis M. Pelus; Chang H. Kim; Giao Hangoc; Scott Cooper; Robert Hromas

Synergistic inhibition in vivo of bone marrow myeloid progenitors by myelosuppressive chemokines and chemokine-accelerated recovery of progenitors after treatment of mice with Ara-C
Experimental Hematology. 2006;34(8):1069-1077.

12
30.
2006

Seiji Fukuda; Louis M. Pelus

Internal tandem duplication of Flt3 modulates chemotaxis and survival of hematopoietic cells by SDF1α but negatively regulates marrow homing in vivo
Experimental Hematology. 2006;34(8):1041-1051.

10
31.
2005

Seiichi Okabe; Seiji Fukuda; Young-June Kim; Masaru Niki; Louis M. Pelus; Kazuma Ohyashiki; Pier Paolo Pandolfi; Hal E. Broxmeyer

Stromal cell-derived factor-1α/CXCL12-induced chemotaxis of T cells involves activation of the RasGAP-associated docking protein p62Dok-1
Blood. 2005;105(2):474-480.

35
32.
2005

S. Fukuda; L.M. Pelus

Growth inhibitory effect of Hcc-1/CIP29 is associated with induction of apoptosis, not just with G₂/M arrest
Cellular and Molecular Life Sciences. 2005;62(13):1526-1527.

8
33.
2005

Zhanxiang Wang; Janardhan Sampath; Seiji Fukuda; Louis M. Pelus

Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis
Cancer Research. 2005;65(18):8224-8232.

30
34.
2005

Ying Guo; Giao Hangoc; Huimin Bian; Louis M. Pelus; Hal E. Broxmeyer

SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells
Stem Cells. 2005;23(9):1324-1332.

67
35.
2005

Louis M. Pelus; Huimin Bian; Seiji Fukuda; Donald Wong; Ahmed Merzouk; Hassan Salari

The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor
Experimental Hematology. 2005;33(3):295-307.

47
36.
2005

Seiji Fukuda; Hal E. Broxmeyer; Louis M. Pelus

Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1α(CXCL12)/CXCR4 axis
Blood. 2005;105(8):3117-3126.

48
37.
2004

Seiji Fukuda; Charlie R. Mantel; Louis M. Pelus

Survivin regulates hematopoietic progenitor cell proliferation through p21^WAF1/Cip1-dependent and -independent pathways
Blood. 2004;103(1):120-127.

48
38.
2004

Louis M. Pelus; Huimin Bian; Andrew G. King; Seiji Fukuda

Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GROβ/CXCL2 and GROβ_T/CXCL2_Δ4
Blood. 2004;103(1):110-119.

98
39.
2004

Seiji Fukuda; Louis M. Pelus

Activated H-Ras regulates hematopoietic cell survival by modulating Survivin
Biochemical and Biophysical Research Communications. 2004;323(2):636-644.

16
40.
2004

Zhanxiang Wang; Seiji Fukuda; Louis M. Pelus

Survivin regulates the p53 tumor suppressor gene family
Oncogene. 2004;23(49):8146-8153.

40
41.
2002

Seiji Fukuda; Ding Wen Wu; Kenneth Stark; Louis M. Pelus

Cloning and characterization of a proliferation-associated cytokine-inducible protein, CIP29
Biochemical and Biophysical Research Communications. 2002;292(3):593-600.

19
42.
2002

Daniel Horowitz; James F. Callahan; Louis M. Pelus; Seiji Fukuda; Andrew G. King

Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products
International Immunopharmacology. 2002;2(5):721-730.

7
43.
2002

Louis M. Pelus; Daniel Horowitz; Scott C. Cooper; Andrew G. King

Peripheral blood stem cell mobilization - A role for CXC chemokines
Critical Reviews in Oncology/Hematology. 2002;43(3):257-275.

43
44.
2002

Seiji Fukuda; Richard G. Foster; Scott B. Porter; Louis M. Pelus

The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34⁺ cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells
Blood. 2002;100(7):2463-2471.

94
45.
2002

Seiji Fukuda; Louis M Pelus

Elevation of Survivin levels by hematopoietic growth factors occurs in quiescent CD34+ hematopoietic stem and progenitor cells before cell cycle entry.
Cell cycle (Georgetown, Tex.). 2002;1(5):322-326.

35
46.
2001

Seiji Fukuda; Louis M. Pelus

Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34⁺ cells by hematopoietic growth factors: Implication of survivin expression in normal hematopoiesis
Blood. 2001;98(7):2091-2100.

148
47.
2001

Andrew G. King; Dan Horowitz; Susan B. Dillon; Robert Levin; Ann M. Farese; Thomas J. MacVittie; Louis M. Pelus

Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GROβ
Blood. 2001;97(6):1534-1542.

73
48.
2001

Seiji Fukuda; Ding W. Wu; Louis M. Pelus

Cloning and characterization of a novel cytokine-inducible protein(p29)
Blood. 2001;96(11 PART II):138b.

0
49.
2000

Connie L. Erickson-Miller; Louis M. Pelus; Kenneth A. Lord

Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: Transient versus sustained proliferation
Stem Cells. 2000;18(5):366-373.

18
50.
2000

Ding Wen Wu; Kenneth C. Stark; Damien Dunnington; Susan B. Dillon; Taolin Yi; Christopher Jones; Louis M. Pelus

SH2-containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells
Blood Cells, Molecules, and Diseases. 2000;26(1):15-24.

11
51.
2000

Andrew G. King; Kyung Johanson; Carrie L. Frey; Peter L. Demarsh; John R. White; Patrick McDevitt; Dean McNulty; Joanna Balcarek; Zdenka L. Jonak; et al.

Identification of unique truncated KC/GROβ chemokines with potent hematopoietic and anti-infective activities
Journal of Immunology. 2000;164(7):3774-3782.

26
52.
2000

Dirk A. Heerding; Melanie Abruzzese; Doreen Alberts; Joelle Burgess; James F. Callahan; William F. Huffman; Andrew G. King; Stephen Locastro; Peter Demarsh; Louis M. Pelus; et al.

Novel peptidomimetic hematoregulatory compounds
Bioorganic and Medicinal Chemistry Letters. 2000;10(6):531-534.

1
53.
1999

Chang H. Kim; Louis M. Pelus; Edward Appelbaum; Kyung Johanson; Naoyuki Anzai; Hal E. Broxmeyer

CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKβ-11/MIP-3β/ELC, are chemoattractants for CD56⁺CD16^- NK cells and late stage lymphoid progenitors
Cellular Immunology. 1999;193(2):226-235.

67
54.
1999

Hal E. Broxmeyer; Chang H. Kim; Scott H. Cooper; Giao Hangoc; Robert Hromas; Louis M. Pelus

Effects of CC, CXC, C, and CX₃C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors
Annals of the New York Academy of Sciences. 1999;872:142-163.

68
55.
1999

S.F. Anderson; H.M. Nash; G.R. Lenz; S.G. Miller; L. Kessler; J.I. Luengo; L. Averill; R.K. Johnson; J.G. Gleason; L.M. Pelus; et al.

A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor
Chemtracts. 1999;12(4):267-271.

0
56.
1998

P.K. Bhatnagar; W.F. Huffman; A.G. King; D. Løvhaug; L.M. Pelus; W.M. Potts; P.L. Smith

Hematoregulators. A case history of a novel hematoregulatory peptide, SK&F 107647.
Pharmaceutical biotechnology. 1998;11:367-391.

0
57.
1998

Chang H. Kim; Louis M. Pelus; John R. White; Hal E. Broxmeyer

Differential chemotactic behavior of developing T cells in response to thymic chemokines
Blood. 1998;91(12):4434-4443.

130
58.
1998

Chang H. Kim; Louis M. Pelus; John R. White; Edward Applebaum; Kyung Johanson; Hal E. Broxmeyer

Ckβ-11/macrophage inflammatory protein-3β/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells
Journal of Immunology. 1998;160(5):2418-2424.

90
59.
1998

Chang H. Kim; Louis M. Pelus; John R. White; Hal E. Broxmeyer

Macrophage-inflammatory protein-3β/EBI1-ligand chemokine/CKβ-11, a CC chemokine, is a chemoattractant with a specificity for macrophage progenitors among myeloid progenitor cells
Journal of Immunology. 1998;161(5):2580-2585.

46
60.
1998

Shin-Shay Tian; Peter Lamb; Andrew G. King; Stephen G. Miller; Linda Kessler; Juan I. Luengo; Laurie Averill; Randall K. Johnson; John G. Gleason; Louis M. Pelus; et al.

A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor
Science. 1998;281(5374):257-259.

133
61.
1997

C.L. Erickson-Miller; C. Hopson; M.N. Sandoli; E.I. Fischer; L.M. Pelus

Cell cycle analysis of cytokine-starved ut7/epc and m-07e cells
Experimental Hematology. 1997;25(8):753.

0
62.
1996

Pradip K. Bhatnagar; Erik K. Agner; Doreen Alberts; Bente E. Arbo; James F. Callahan; Allan S. Cuthbertson; Steinar J. Engelsen; Hege Fjerdingstad; Michael Hartmann; Dirk Heerding; et al.

Structure-activity relationships of novel hematoregulatory peptides
Journal of Medicinal Chemistry. 1996;39(19):3814-3819.

26
63.
1996

P.K. Bhatnagar; D. Alberts; J.F. Gallahan; D. Heerding; W.F. Huffman; A.G. King; S. LoCastro; L.M. Pelus; J.S. Takata

Development of a pharmacophore model for a novel hematoregulatory peptide
Journal of the American Chemical Society. 1996;118(50):12862-12863.

9
64.
1995

D.P. Brooks; L.C. Contino; S. Perez; L.M. Pelus

Responsiveness of rats with chronic renal failure-induced anemia to recombinant human erythropoietin
Pharmacology Communications. 1995;6(4):319-325.

0
65.
1994

L.M. Pelus; A.G. King; H.E. Broxmeyer; P.L. DeMarsh; S.R. Peteway; P.K. Bhatnagar

In vivo modulation of hematopoiesis by a novel hematoregulatory peptide
Experimental Hematology. 1994;22(3):239-247.

13
66.
1992

A.G. King; J.E. Talmadge; A.M. Badger; L.M. Pelus

Regulation of colony-stimulating activity production from bone marrow stromal cells by the hematoregulatory peptide, HP-5
Experimental Hematology. 1992;20(2):223-228.

14
67.
1991

J.E. Talmadge; L.M. Pelus; P.L. Black; F. Abe

Hematopoietic and therapeutic properties of Bestatin in normal and myelosuppressed mice
Biomedicine and Pharmacotherapy. 1991;45(2-3):61-69.

5
68.
1990

J.E. Talmadge; P.L. Black; L.M. Pelus; F. Abe

Hematopoietic and hematologic properties of bestatin in normal and cyclophosphamide myelosuppressed mice
Biomedicine and Pharmacotherapy. 1990;44(2):85-91.

0
69.
1989

Louis M. Pelus

Modulation of myelopoiesis by prostaglandin E₂: Demonstration of a novel mechanism of action in vivo
Immunologic Research. 1989;8(3):176-184.

14
70.
1989

K.H. Nocka; O.G. Ottman; L.M. Pelus

The role of marrow accessroy cell populations in the augmentation of human erythroid progenitor cell (BFU-E) proliferation by prostaglandin E
Leukemia Research. 1989;13(7):527-534.

4
71.
1989

O.G. Ottmann; M. Abboud; K. Welte; L.M. Souza; L.M. Pelus

Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors
Experimental Hematology. 1989;17(2):191-197.

12
72.
1989

L.M. Pelus

Blockade of prostaglandin biosynthesis in intact mice dramatically augments the expansion of committed myeloid progenitor cells (colony-forming units-granulocyte, macrophage) after acute administration of recombinant human IL-1α
Journal of Immunology. 1989;143(12):4171-4179.

17
73.
1988

P.S. Gentile; L.M. Pelus

In vivo modulation of myelopoiesis by prostaglandin E₂. IV. Prostaglandin E₂ induction of myelopoietic inhibitory activity
Journal of Immunology. 1988;141(8):2714-2720.

9
74.
1988

O.G. Ottmann; K.H. Nocka; M.A.S. Moore; L.M. Pelus

Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells
Leukemia. 1988;2(10):677-686.

4
75.
1988

L.M. Pelus; E. Levi; K. Welte

The response of human marrow colony-forming units-granulocyte and macrophage to inhibition by prostaglandin E and acidic isoferritins is associated with expression of MHC class II antigens and requires the participation of a CD8⁺ T lymphokine
Journal of Immunology. 1988;141(5):1658-1664.

1
76.
1988

K.H. Nocka; L.M. Pelus

Cell cycle specific effects of deferoxamine on human and murine hematopoietic progenitor cells
Cancer Research. 1988;48(13):3571-3575.

6
77.
1988

L.M. Pelus; O.G. Ottmann; K.H. Nocka

Synergistic inhibition of human marrow granulocyte-macrophage progenitor cells by prostaglandin E and recombinant interferon-α, -β, and -γ and an effect mediated by tumor necrosis factor
Journal of Immunology. 1988;140(2):479- 484.

8
78.
1988

O.G. Ottmann; L.M. Pelus

Differential proliferative effects of transforming growth factor-β on human hematopoietic progenitor cells
Journal of Immunology. 1988;140(8):2661- 2665.

63
79.
1988

L.M. Pelus; S. Vadhan-Raj

Modulation of responsiveness of chronic myelogenous leukemia granulocyte-macrophage colony-forming cells to growth regulation following in vivo treatment with recombinant γ-interferon
American Journal of Hematology. 1988;28(1):21-26.

2
80.
1988

L.M. Pelus; P.S. Gentile

In vivo modulation of myelopoiesis by prostaglandin E₂. III. Induction of suppressor cells in marrow and spleen capable of mediating inhibition of CFU-GM proliferation
Blood. 1988;71(6):1633-1640.

15
81.
1987

P.S. Gentile; L.M. Pelus

In vivo modulation of myelopoiesis by prostaglandin E₂. II. Inhibition of granulocyte-monocyte progenitor cell (CFU-GM) cell-cycle rate
Experimental Hematology. 1987;15(2):119-126.

12
82.
1987

S.P. Leitner; G.J. Bosl; L.M. Pelus

Abnormal colony formation and prostaglandin E responsiveness of myeloid progenitor cells in patients cured of germ cell neoplasms after combination chemotherapy
Cancer. 1987;60(3):312-317.

3
83.
1987

L. Lu; L.M. Pelus; W. Piacibello; M.A.S. Moore; W. Hu; H.E. Broxmeyer

Prostaglandin E acts at two levels to enhance colony formation in vitro by erythroid (BFU-E) progenitor cells
Experimental Hematology. 1987;15(7):765-771.

6
84.
1986

H.E. Broxmeyer; D.C. Bicknell; S. Gillis; E.L. Harris; L.M. Pelus; G.W. Sledge Jr.

Lactoferrin: Affinity purification from human milk and polymorphonuclear neutrophils using monoclonal antibody (II 2C) to human lactoferrin, development of an immunoradiometric assay using II 2C, and myelopoietic regulation and receptor-binding characteristics
Blood Cells. 1986;11(3):429-446.

9
85.
1986

L. Lu; L.M. Pelus; H.E. Broxmeyer; M.A. Moore; M. Wachter; D. Walker; E. Platzer

Enhancement of the proliferation of human marrow erythroid (BFU-E) progenitor cells by prostaglandin E requires the participation of OKT8-positive T lymphocytes and is associated with the density expression of major histocompatibiliy complex class II antigens on BFU-E
Blood. 1986;68(1):126-133.

7
86.
1986

S. Vadhan-Raj; A. Al-Katib; R. Bhalla; L. Pelus; C.F. Nathan; S.A. Sherwin; H.F. Oettgen; S.E. Krown

Phase I trial of recombinant interferon gamma in cancer patients
Journal of Clinical Oncology. 1986;4(2):137-146.

22
87.
1986

D. Løvhaug; L.M. Pelus; E.M. Nordlie; A. Bøyum; M.A. Moore

Monocyte-conditioned medium and interleukin 1 induce granulocyte-macrophage colony-stimulating factor production in the adherent cell layer of murine bone marrow cultures
Experimental Hematology. 1986;14(11):1037-1042.

7
88.
1985

S. Leitner; L.M. Pelus; C. Cappello; G.J. Bosl

Hematopoietic function in germ cell tumor (GCT) patients (Pts) in complete remission (CR) after cisplatin (DDP)-based chemotherapy (CRx)
Proceedings of the American Association for Cancer Research. 1985;VOL. 26:No. 587.

0
89.
1985

L.G. Freund; E. Hippe; S. Strandgaard; L.M. Pelus; A.J. Erslev

Complete remission in pure red cell aplasia after plasmapheresis
Scandinavian Journal of Haematology. 1985;35(3):315-318.

5
90.
1984

L. Lu; L.M. Pelus; H.E. Broxmeyer

Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E
Experimental Hematology. 1984;12(9):741-748.

9
91.
1984

L.M. Pelus

Prostaglandin-E-mediated modulation of human marrow CFU-GM Ia-antigen expression: Kinetics and specificity
Experimental Hematology. 1984;12(11):831-837.

1
92.
1983

K.T. Pearlstein; L. Staiano-Coico; R.A. Miller; L.M. Pelus; M.E. Kirch; O. Stutman; M.A. Palladino

Multiple lymphokine production by a phorbol ester-stimulated mouse thymoma: Relationship to cell cycle events
Journal of the National Cancer Institute. 1983;71(3):583-590.

4
93.
1983

L.M. Pelus; E. Gold; S. Saletan; M. Coleman

Restoration of responsiveness of chronic myeloid leukemia granulocyte-macrophage colony-forming cells to growth regulation in vitro following preincubation with prostaglandin E
Blood. 1983;62(1):158-165.

6
94.
1983

E.J. Gold; M. Conjalka; L.M. Pelus; S.C. Jhanwar; H. Broxmeyer; A.B. Middleton; B.D. Clarkson; M.A. Moore

Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: Insights to pathophysiology and prognosis
Journal of Clinical Oncology. 1983;1(10):627-634.

19
95.
1983

P. Gentile; D. Byer; L.M. Pelus

In vivo modulation of murine myelopoiesis following intravenous administration of prostaglandin E₂
Blood. 1983;62(5):1100-1107.

22
96.
1982

L.M. Pelus

Association between colony forming units-granulocyte macrophage expression of Ia-like (HLA-DR) antigen and control of granulocyte and macrophage production. A new role for prostaglandin E
Journal of Clinical Investigation. 1982;70(3):568-578.

8
97.
1982

L.M. Pelus; S. Saletan; R.T. Silver; M.A.S. Moore

Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E
Blood. 1982;59(2):284-292.

2
98.
1981

M.A.S. Moore; R. Mertelsmann; L.M. Pelus

Phenotypic evaluation of chronic myeloid leukemia
Blood Cells. 1981;7(2):217-236.

5
99.
1981

L.M. Pelus; H.E. Broxmeyer; M.A.S. Moore

Regulation of human myelopoiesis by prostaglandin E and lactoferrin
Cell and Tissue Kinetics. 1981;14(5):515-526.

11
100.
1981

L.M. Pelus; H.E. Broxmeyer; M. DeSousa; M.A.S. Moore

Heterogeneity among resident murine peritoneal macrophages: Separation and functional characterization of monocytoid cells producing granulocyte-macrophage colony-stimulating factor (GM-CSF) and responding to regulation by lactoferrin
Journal of Immunology. 1981;126(3):1016-1021.

1
101.
1981

L. Lu; H.E. Broxmeyer; L.M. Pelus; M. Andreeff; M.A. Moore

Detection of Luxol-fast-blue positive cells in human promyelocytic leukemia cell line HL-60
Experimental Hematology. 1981;9(9):887-892.

3
102.
1980

L.M. Pelus; H.E. Broxmeyer; B.D. Clarkson; M.A.S. Moore

Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E
Cancer Research. 1980;40(7):2512-2515.

3
103.
1980

H.E. Broxmeyer; R. Pahwa; N. Jacobsen; L.M. Pelus; P. Ralph; P.A. Meyers; S. Pahwa; N. Kapoor

Specific inhibitory activity against granulocyte-progenitor cells produced by non-T lymphocytes from patients with neutropenia
Experimental Hematology. 1980;8(3):278-297.

1
104.
1980

L.M. Pelus; H.E. Broxmeyer; M.A.S. Moore

Regulation of human myeloid stem cell proliferation by prostaglandin E and lactoferrin
Journal of Supramolecular and Cellular Biochemistry. 1980;12(SUPPL. 4):No. 366.

0
105.
1979

L.M. Pelus; H.E. Broxmeyer; J.I. Kurland; M.A.S. Moore

Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin
Journal of Experimental Medicine. 1979;150(2):277-292.

15
106.
1979

L.M. Pelus; R.S. Bockman

Increased prostaglandin synthesis by macrophages from tumor-bearing mice
Journal of Immunology. 1979;123(5):2118-2125.

9
107.
1979

J.I. Kurland; L.M. Pelus; P. Ralph; R.S. Bockman; M.A. Moore

Induction of prostaglandin E synthesis in normal and neoplastic macrophages: Role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation
Proceedings of the National Academy of Sciences of the United States of America. 1979;76(5):2326-2330.

21
108.
1978

M.M. Rosenstein; L.M. Pelus; H.R. Strousser

Host-mediated immune suppression in tumor bearing mice: In vitro reversal by indomethacin or removal of adherent cells
Federation Proceedings. 1978;37(6):No. 1006.

0
109.
1978

J.I. Kurland; H.E. Broxmeyer; L.M. Pelus; R.S. Bockman; M.A. Moore

Role for monocyte macrophage derived colony stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation
Blood. 1978;52(2):388-407.

18
110.
1977

L.M. Pelus; H.R. Strausser

Prostaglandins and the immune response
Life Sciences. 1977;20(6):903-914.

9
111.
1977

J.L. Humes; R.J. Bonney; L. Pelus; M.E. Dahlgren; S.J. Sadowski; F.A. Kuehl; P. Davies

Macrophages synthesise and release prostaglandins in response to inflammatory stimuli
Nature. 1977;269(5624):149-151.

58
112.
1976

L.M. Pelus; H.R. Strausser

Indomethacin enhancement of spleen cell responsiveness to mitogen stimulation in tumorous mice
International Journal of Cancer. 1976;18(5):653-660.

1
113.
1976

M.M. Rosenstein; L.M. Pelus; H.R. Strausser

Increase in plaque forming cells and phytohemagglutinin response and decrease in tumor size upon treatment with peritoneal cell culture supernatants
Federation Proceedings. 1976;35(3):no. 3430.

0
114.
1975

L.M. Pelus; J.L. Humes; H.R. Strausser

Prostaglandin levels in virus and chemically induced mouse tumors
Federation Proceedings. 1975;34(3):No. 3438.

0

Louis M. Pelus School of Medicine, Microbiology & Immunology

Louis M. Pelus

114 Publications

Louis M. Pelus
School of Medicine, Microbiology & Immunology